local
Study shows a blood test can help identify healthy people at high risk for Alzheimer's disease
By AP at ABC7 News (KGO-TV, ABC)
· July 15, 2026
· 1 min read
Already large clinical trials are testing if certain drugs could prevent or at least delay the disease - and if any of those pan out, doctors will need an easy way to tell who should try them.
Why this matters in The San Francisco
The potential for a blood test to identify healthy individuals at high risk for Alzheimer's disease has significant implications for San Francisco 's healthcare landscape. As clinical trials explore preventative treatments, the ability to easily identify at-risk populations will be crucial in determining who may benefit from these potential therapies. San Francisco's aging population and high cost of living may exacerbate the challenges of caring for those with Alzheimer's, making preventative measures particularly valuable. If effective preventative treatments emerge, the city's healthcare providers will need to be equipped to administer them to those who need it most, and a reliable blood test could be a key tool in this effort. The city's medical research institutions and healthcare providers will likely play a significant role in implementing and refining this technology, should it become available.
About this story
Original reporting by ABC7 News (KGO-TV, ABC) . The San Francisco surfaces reporting from trusted publishers and adds local editorial context so readers can quickly understand what a story means for their community. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit ABC7 News (KGO-TV, ABC) . Have a tip or correction? Contact our newsroom .
Category: local ·
Published: July 15, 2026 ·
Source: ABC7 News (KGO-TV, ABC) ·
Reading time: 1 min
Get more The San Francisco stories like this
Free weekly briefing covering local and other local news. Curated by our editorial team. No spam.
By subscribing you agree to our privacy policy . Unsubscribe anytime.
Frequently asked about this story
What is this story about? Already large clinical trials are testing if certain drugs could prevent or at least delay the disease - and if any of those pan out, doctors will need an easy way to tell who should try them.
When was this published? This article was first published on July 15, 2026 by ABC7 News (KGO-TV, ABC) and curated for The San Francisco readers.
Who reported this story? This story was reported by AP at ABC7 News (KGO-TV, ABC). To learn more about how The San Francisco selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more local coverage from The San Francisco, or browse our daily briefing and topic hubs .
← Back to all news
More local →
Today’s briefing
Subscribe to newsletter